» Articles » PMID: 28791797

Emerging Roles of HnRNPA1 in Modulating Malignant Transformation

Overview
Publisher Wiley
Date 2017 Aug 10
PMID 28791797
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Heterogeneous nuclear ribonucleoproteins (hnRNPs) are RNA-binding proteins associated with complex and diverse biological processes such as processing of heterogeneous nuclear RNAs (hnRNAs) into mature mRNAs, RNA splicing, transactivation of gene expression, and modulation of protein translation. hnRNPA1 is the most abundant and ubiquitously expressed member of this protein family and has been shown to be involved in multiple molecular events driving malignant transformation. In addition to selective mRNA splicing events promoting expression of specific protein variants, hnRNPA1 regulates the gene expression and translation of several key players associated with tumorigenesis and cancer progression. Here, we will summarize our current knowledge of the involvement of hnRNPA1 in cancer, including its roles in regulating cell proliferation, invasiveness, metabolism, adaptation to stress and immortalization. WIREs RNA 2017, 8:e1431. doi: 10.1002/wrna.1431 For further resources related to this article, please visit the WIREs website.

Citing Articles

STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis.

Pan Y, Liu S, Shu G, Chen M, Fu L, Chen C Cell Death Dis. 2025; 16(1):125.

PMID: 39988631 PMC: 11847927. DOI: 10.1038/s41419-025-07456-9.


Enhanced identification of small molecules binding to hnRNPA1 via cryptic pockets mapping coupled with X-Ray fragment screening.

Dunnett L, Das S, Venditti V, Prischi F bioRxiv. 2025; .

PMID: 39763864 PMC: 11702612. DOI: 10.1101/2024.12.17.628909.


Bioinformatics Analysis of Biomarkers and Therapeutic Targets Related to Necroptosis in Intervertebral Disc Degeneration.

Zhang F, Yuan L, Ding H, Lou Z, Li X Biomed Res Int. 2024; 2024:9922966.

PMID: 39717265 PMC: 11666314. DOI: 10.1155/bmri/9922966.


Model ensembling as a tool to form interpretable multi-omic predictors of cancer pharmacosensitivity.

De Landtsheer S, Badkas A, Kulms D, Sauter T Brief Bioinform. 2024; 25(6).

PMID: 39494610 PMC: 11532660. DOI: 10.1093/bib/bbae567.


Quercetin and Thyroid.

Giuliani C, Di Dalmazi G, Bucci I, Napolitano G Antioxidants (Basel). 2024; 13(10).

PMID: 39456456 PMC: 11505551. DOI: 10.3390/antiox13101202.